Term | Description | Count | % | Log10 [p value] | Log10 [q value] |
---|---|---|---|---|---|
GO Biological process | |||||
Ā GO:0006935 | Chemotaxis | 117 | 5.89 | ā15.44 | ā11.44 |
Ā GO:0010817 | Regulation of hormone levels | 102 | 5.13 | ā15.05 | ā11.33 |
Ā GO:1,901,615 | Organic hydroxy compound metabolic process | 100 | 5.03 | ā13.61 | ā10.01 |
Ā GO:0043062 | Extracellular structure organization | 82 | 4.13 | ā12.37 | ā8.87 |
Ā GO:0015711 | Organic anion transport | 85 | 4.28 | ā10.60 | ā7.25 |
Ā GO:0072006 | Nephron development | 37 | 1.86 | ā9.56 | ā6.40 |
Ā GO:0048514 | Blood vessel morphogenesis | 105 | 5.28 | ā9.29 | ā6.20 |
Ā GO:0009611 | Response to wounding | 105 | 5.28 | ā9.25 | ā6.20 |
Ā GO:0051047 | Positive regulation of secretion | 75 | 3.77 | ā9.14 | ā6.11 |
Ā GO:0006869 | Lipid transport | 66 | 3.32 | ā9.03 | ā6.06 |
Ā GO:0008285 | Negative regulation of cell proliferation | 113 | 5.69 | ā8.91 | ā6.01 |
Ā GO:0052548 | Regulation of endopeptidase activity | 73 | 3.67 | ā8.70 | ā5.86 |
Ā GO:0032787 | Monocarboxylic acid metabolic process | 97 | 4.88 | ā8.15 | ā5.36 |
Ā GO:0008610 | Lipid biosynthetic process | 103 | 5.18 | ā7.83 | ā5.11 |
Ā GO:0003013 | Circulatory system process | 83 | 4.18 | ā7.17 | ā4.54 |
Ā GO:0048598 | Embryonic morphogenesis | 87 | 4.38 | ā6.84 | ā4.26 |
Ā GO:0030155 | Regulation of cell adhesion | 99 | 4.98 | ā6.68 | ā4.14 |
Ā GO:0046683 | Response to organophosphorus | 31 | 1.56 | ā6.68 | ā4.14 |
Ā GO:0035272 | Exocrine system development | 17 | 0.86 | ā6.62 | ā4.11 |
Ā GO:0015718 | Monocarboxylic acid transport | 35 | 1.76 | ā6.53 | ā4.04 |
GO molecular function | |||||
Ā GO:0008289 | Lipid binding | 104 | 5.23 | ā6.90 | ā3.45 |
Ā GO:0004857 | Enzyme inhibitor activity | 62 | 3.12 | ā6.81 | ā3.45 |
Ā GO:0005509 | Calcium ion binding | 97 | 4.88 | ā6.45 | ā3.37 |
Ā GO:0008201 | Heparin binding | 34 | 1.71 | ā6.05 | ā3.17 |
Ā GO:0008514 | Organic anion transmembrane transporter activity | 39 | 1.96 | ā5.75 | ā3.06 |
Ā GO:0048018 | Receptor ligand activity | 70 | 3.52 | ā5.72 | ā3.06 |
Ā GO:0000987 | Proximal promoter sequence-specific DNA binding | 84 | 4.23 | ā5.16 | ā2.65 |
Ā GO:0016491 | Oxidoreductase activity | 95 | 4.78 | ā4.82 | ā2.41 |
Ā GO:0005201 | Extracellular matrix structural constituent | 30 | 1.51 | ā4.52 | ā2.18 |
Ā GO:0016298 | Lipase activity | 25 | 1.26 | ā4.46 | ā2.16 |
Ā GO:0033293 | Monocarboxylic acid binding | 18 | 0.91 | ā4.39 | ā2.14 |
Ā GO:0043178 | Alcohol binding | 19 | 0.96 | ā4.39 | ā2.14 |
Ā GO:0015144 | Carbohydrate transmembrane transporter activity | 12 | 0.60 | ā4.35 | ā2.12 |
Ā GO:0033764 | Steroid dehydrogenase activity | 10 | 0.50 | ā4.05 | ā1.90 |
Ā GO:0030515 | snoRNA binding | 10 | 0.50 | ā4.05 | ā1.90 |
Ā GO:0042803 | Protein homodimerization activity | 81 | 4.08 | ā4.04 | ā1.90 |
Ā GO:0008233 | Peptidase activity | 78 | 3.93 | ā3.82 | ā1.73 |
Ā GO:0004745 | Retinol dehydrogenase activity | 8 | 0.40 | ā3.80 | ā1.73 |
Ā GO:0019955 | Cytokine binding | 24 | 1.21 | ā3.69 | ā1.63 |
Ā GO:0015250 | Water channel activity | 6 | 0.30 | ā3.50 | ā1.46 |
GO cellular component | |||||
Ā GO:0031012 | Extracellular matrix | 98 | 4.93 | ā13.46 | ā10.17 |
Ā GO:0016324 | Apical plasma membrane | 68 | 3.42 | ā11.60 | ā8.79 |
Ā GO:0044420 | Extracellular matrix component | 17 | 0.86 | ā6.08 | ā3.57 |
Ā GO:0016323 | Basolateral plasma membrane | 41 | 2.06 | ā5.91 | ā3.52 |
Ā GO:0031253 | Cell projection membrane | 56 | 2.82 | ā5.90 | ā3.52 |
Ā GO:0005604 | Basement membrane | 23 | 1.16 | ā5.55 | ā3.21 |
Ā GO:0031526 | Brush border membrane | 16 | 0.81 | ā5.25 | ā2.97 |
Ā GO:0031091 | Platelet alpha granule | 21 | 1.06 | ā4.93 | ā2.72 |
Ā GO:0030684 | Pre-ribosome | 19 | 0.96 | ā4.87 | ā2.70 |
Ā GO:0005667 | Transcription factor complex | 53 | 2.67 | ā4.60 | ā2.46 |
Ā GO:0070161 | Anchoring junction | 71 | 3.57 | ā3.64 | ā1.68 |
Ā GO:0044452 | Nucleolar part | 29 | 1.46 | ā3.61 | ā1.67 |
Ā GO:0005911 | Cell-cell junction | 53 | 2.67 | ā3.49 | ā1.60 |
Ā GO:0005773 | Vacuole | 93 | 4.68 | ā3.40 | ā1.56 |
Ā GO:0005777 | Peroxisome | 24 | 1.21 | ā3.40 | ā1.56 |
Ā GO:0034358 | Plasma lipoprotein particle | 10 | 0.50 | ā3.32 | ā1.52 |
Ā GO:0000940 | Condensed chromosome outer kinetochore | 6 | 0.30 | ā3.29 | ā1.52 |
Ā GO:0071438 | Invadopodium membrane | 4 | 0.20 | ā3.22 | ā1.48 |
Ā GO:0048471 | Perinuclear region of cytoplasm | 85 | 4.28 | ā3.20 | ā1.47 |
Ā GO:0005593 | FACIT collagen trimer | 4 | 0.20 | ā2.88 | ā1.25 |
KEGG pathway | |||||
Ā hsa04974 | Protein digestion and absorption | 23 | 1.16 | ā6.16 | ā3.46 |
Ā hsa04060 | Cytokine-cytokine receptor interaction | 45 | 2.26 | ā5.38 | ā2.98 |
Ā hsa00830 | Retinol metabolism | 17 | 0.86 | ā4.86 | ā2.64 |
Ā hsa04510 | Focal adhesion | 34 | 1.71 | ā4.45 | ā2.36 |
Ā hsa04918 | Thyroid hormone synthesis | 17 | 0.86 | ā4.08 | ā2.08 |
Ā hsa04610 | Complement and coagulation cascades | 17 | 0.86 | ā3.71 | ā1.85 |
Ā hsa04310 | Wnt signaling pathway | 24 | 1.21 | ā3.21 | ā1.49 |
Ā hsa03320 | PPAR signaling pathway | 15 | 0.75 | ā3.18 | ā1.49 |
Ā hsa05323 | Rheumatoid arthritis | 17 | 0.86 | ā3.02 | ā1.36 |
Ā hsa05146 | Amoebiasis | 17 | 0.86 | ā2.70 | ā1.27 |
Ā hsa04540 | Gap junction | 16 | 0.81 | ā2.69 | ā1.27 |
Ā hsa00471 | D-Glutamine and D-glutamate metabolism | 3 | 0.15 | ā2.68 | ā1.27 |
Ā hsa04978 | Mineral absorption | 11 | 0.55 | ā2.60 | ā1.21 |
Ā hsa04146 | Peroxisome | 15 | 0.75 | ā2.53 | ā1.16 |
Ā hsa04621 | NOD-like receptor signaling pathway | 25 | 1.26 | ā2.49 | ā1.14 |
Ā hsa04390 | Hippo signaling pathway | 23 | 1.16 | ā2.42 | ā1.13 |
Ā hsa00590 | Arachidonic acid metabolism | 12 | 0.60 | ā2.38 | ā1.13 |
Ā hsa00564 | Glycerophospholipid metabolism | 16 | 0.81 | ā2.35 | ā1.12 |
Ā hsa04976 | Bile secretion | 13 | 0.65 | ā2.32 | ā1.10 |
Ā hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 13 | 0.65 | ā2.26 | ā1.06 |